We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

AngioDynamics Inc (ANGO) USD0.01

Sell:$19.53 Buy:$19.54 Change: $0.19 (0.98%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $0.19 (0.98%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $0.19 (0.98%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

Contact details

14 Plaza Dr
United States
+1 (518) 7981215

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$757.76 million
Shares in issue:
38.78 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • James Clemmer
    President, Chief Executive Officer, Director
  • Stephen Trowbridge
    Chief Financial Officer, Executive Vice President
  • Richard Rosenzweig
    Senior Vice President, General Counsel, Secretary
  • Chad Campbell
    Senior Vice President, General Manager - Vascular Access
  • Scott Centea
    Senior Vice President, General Manager- Endovasular Therapies
  • Laura Piccinini
    Senior Vice President, General Manager - International
  • Marna Bronfenmoore
    Senior Vice President of Human Resources
  • Benjamin Davis
    Senior Vice President - Business Development
  • David Helsel
    Senior Vice President - Global Operations
  • Warren Nighan
    Senior Vice President - Quality and Regulatory Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.